There has been growing interest in the use of cannabis-based products for the treatment of a wide range of diseases, including epilepsy.
A number of studies were published during the last 5 years demonstrating efficacy of purified CBD for the control of a large spectrum of seizure-types, particularly those observed in severe childhood epilepsies, such as Lennox- Gastaut and Dravet syndromes.
This book, co-authored by leaders in the field of epileptology, critically reviews recent data from clinical trials. Authors discuss issues related to pharmacology, drug interactions, efficacy, potential adverse events and long-term effects on development and behaviour. Child and adult neurologists and all clinicians contributing to epilepsy care will find useful information on the best practices, when using purified CBD for the treatment of
drug-resistant epilepsies.
Collection : Epileptic disorders
Publication : 1 octobre 2020
Edition : 1ère édition
Intérieur : Noir & blanc
Support(s) : Contenu téléchargeable [ePub]
Contenu(s) : ePub
Taille(s) : 5,16 Mo (ePub)
Langue(s) : Anglais
Code(s) CLIL : 3173
EAN13 Contenu téléchargeable [ePub] : 9782742016556
EAN13 (papier) : 9782742016334
Emilio Fernandez-Alvarez, Alexis Arzimanoglou, Eduardo Tolosa
52,99 €
Emilio Fernandez-Alvarez, Alexis Arzimanoglou, Eduardo Tolosa
52,99 €
52,99 €
Guido Rubboli, Carlo Alberto Tassinari
À partir de 30,99 €
52,99 €
Guido Rubboli, Carlo Alberto Tassinari
À partir de 30,99 €
52,99 €
Guido Rubboli, Carlo Alberto Tassinari
À partir de 30,99 €